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SUMMARY
Purpose: We performed this analysis of possible
first night effects (FNEs) on sleep and respiratory
parameters in order to evaluate the need for two
serial night polysomnograms (PSGs) to diagnose
obstructive sleep apnea (OSA) in epilepsy patients.
Methods: As part of a pilot multicenter clinical
trial investigating the effects of treating sleep
apnea in epilepsy, two nights of PSG recording
were performed for 40 patients with refractory
epilepsy and OSA symptoms. Sleep architecture
was examined in detail, along with respiratory
parameters including apnea/hypopnea index
(AHI) and minimum oxygen saturation. Analysis
included two-tailed t-tests, Wilcox sign rank analy-
sis, and Bland Altman measures of agreement.
Results: Total sleep time differed between the two
nights (night 1,363.8 min + 59.4 vs. 386.3 min +
68.6, p ¼ 0.05). Rapid eye movement (REM) sleep
and percentage of REM sleep were increased
during night two (night 1: 12.3% + 5.9 vs. night 2:
15.5% + 6.2, p ¼ 0.007), and the total minutes of
slow-wave sleep (SWS) were increased (night 1:
35.6 + 60.7 vs. night 2: 46.4 + 68.1, p ¼ 0.01). No
other sleep or respiratory variables differed
between the two nights. Given an AHI inclusion
criterion of five apneas per hour, the first PSG
identified all but one patient with OSA.
Discussion: Respiratory parameters showed little
variability between the first and second nights.
Sleep architecture was mildly different between
the first and second PSG night. Performing two
consecutive baseline PSGs to diagnose OSA may
not be routinely necessary in this population.
KEY WORDS: First night effect, Polysomnogram,
Epilepsy, Obstructive sleep apnea, Rapid eye
movement (REM) sleep, Slow-wave sleep (SWS).
In patients with epilepsy, studies of sleep architecture
and respiratory disturbances have been a fruitful area of
clinical investigation. Treatment of sleep apnea in those
with refractory seizures may improve seizure frequency,
quality of life, and daytime sleepiness (Wyler & Weymuller,
1981; Devinsky et al., 1994; Vaughn et al., 1996; Malow
et al., 1997; Koh et al., 2000). One of the challenges,
however, to investigators conducting polysomnogram
(PSG)-based research in patients with epilepsy is the pos-
sibility of a first-night effect, and the possible need for two
consecutive nights of polysomnography. The first night
effect (FNE) is well-studied in the normal population and
was first described in 1966 (Agnew et al., 1966). In control
subjects, the first PSG night often has a longer sleep
latency, less rapid eye movement (REM), and decreased
sleep efficiency than subsequent nights of study, and this
phenomenon is usually felt to represent habituation to the
sleep environment (Toussaint et al., 1997). Respiratory
parameters have also been demonstrated to change over
repeated nights of testing (LeBon et al., 2000), and varia-
tions in the apnea/hypopnea index (AHI) on the second
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PSG are seen in children and the elderly as well as normal
adult subjects (Waquier et al., 1991; Scholle et al., 2003;
Li et al., 2004). However, the FNE seems to vary in differ-
ent disease states—for instance, psychiatric inpatients
have a much less pronounced FNE than controls
(Toussaint et al., 1995).
The differences that have been noted in the sleep archi-
tecture of epilepsy patients may influence the degree of
FNE in this population. The amount of REM sleep is often
less than that noted in control populations, while stage 1
sleep may be increased (Marzec et al., 2005), and epilepti-
form activity is present mainly during non-rapid eye
movement (NREM) sleep and may prove disruptive
(Samaritano et al., 1991; Malow et al., 1998). These
patients may be more prone to a FNE than the general
population because they are more prone to disturbed sleep
even outside of the laboratory, (DeWeerd et al., 2004),
and already have a lower percentage of REM sleep. On the
other hand, prior experience with EEG testing may allow
them to acclimate more readily to the testing environment.
Epilepsy patients have significantly increased daytime
somnolence (Salinski et al., 1996), and their sleep latency
and stage 1 sleep could be shorter than that of controls on
their first night.
In our prior analysis of sleep architecture in 53 patients
with medically refractory epilepsy studied at one site, dur-
ing the second night of PSG compared to the first, patients
exhibited a mild increase in slow-wave sleep (SWS) and a
trend toward increased total sleep time (Marzec et al.,
2005). In planning a pilot trial to evaluate treatment of
obstructive sleep apnea (OSA) in patients with medically
refractory epilepsy, we wished to confirm these findings
in an independent cohort of patients studied at four differ-
ent sites and also wished to include respiratory parameters
(AHI and minimum oxygen saturation). Our hypothesis
was that one night of PSG would be sufficient to make the
diagnosis of OSA in a cohort of patients suspected of hav-
ing OSA based on screening questionnaires and clinical
evaluation.
Methods
Adult patients with refractory epilepsy were identified
for enrollment in a study of the effects of treating sleep
apnea on seizure frequency. Inclusion criteria included a
frequency of two or more seizures per month (partial or
generalized, auras excluded) that could be accurately
quantified and a high clinical suspicion for OSA based
upon a questionnaire addressing risk factors for OSA
including BMI, snoring, and other clinical symptoms (for
detail, see references Douglass et al., 1994; Weatherwax
et al., 2003). Institution Review Board approval was
obtained to study the effects of identification and treat-
ment of sleep apnea in these subjects, and a detailed
informed consent was obtained.
Patients enrolled in this fashion at four centers under-
went two consecutive nights of research polysomnogra-
phy. The PSGs were recorded on 32 channel digital
systems. Recording montages were standardized to
include chin electromyography (EMG), electrocardio-
gram (EKG), Limb EMG, nasal/oral airflow (thermocou-
ples), thoracic and abdominal excursion (piezo-electric
bands), electro-oculograms, pulse oximetry, and monitor-
ing of snoring. The EEG montage was an extended eight
channel parasagittal montage. Sleep studies were scored
in 30 s epochs according to the usual standard guidelines,
and all were scored in a blinded fashion by one coauthor
and subsequently verified by a second coauthor
(Rechtshaffen & Kales, 1968).
Analysis of the data included evaluation of the median,
mean, and standard deviation of the following variables
for the first and the second night of study: total sleep time,
sleep efficiency, sleep latency, wakefulness and arousals,
total stage 1 sleep, stage 2 sleep, stages 3 and 4 sleep
(SWS), REM sleep, AHI, and percent minimum oxygen
saturation. Wilcoxon signed-rank tests were conducted to
compare the first night to the second night sleep parame-
ters for each of these variables. No medication changes
were made between the first and second nights of
recording. Adjustment for multiple comparisons was
avoided in order to screen most effectively for any
possible clinically-significant differences between nights.
A Bland–Altman agreement plot was also performed to
compare the first and second night apnea-hypopnea
indices 21 (Bland & Altman, 1986).
Results
Forty-three subjects were recruited for the study, but
three were eventually excluded from analysis of FNE
because of seizures that occurred in one of the two study
nights. The average age of the group was 40 years (range
19–61, see standard deviations in Table 1). There were 21
women and 19 men enrolled, with an average BMI of
32.4. Six patients had a generalized epilepsy syndrome
and the rest had refractory partial epilepsy, based on imag-
ing, prior EEG, and semiologic characteristics. Mean
baseline seizure frequency was 13 per month, and average
Table 1. Patient demographics
Variable Mean (± SD)
Age 40.2 (±12.2)
Sex M/F 19/21
BMI 32.4 (± 8.1)
Partial/generalized epilepsy 34/6
Baseline monthly seizure frequency 12.5 (±23.9)
Age at onset 15.9 (±13.7)
Number of antiepileptic drugs (AEDs) 1.90 (±0.67)
Number of non-AED psychoactive medications 0.70 (±0.88)
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age of onset was 16. These patients were receiving an
average of two antiepileptic drugs (16 patients were on
monotherapy, see Table 1) and one other psychoactive
medication (including medicines for anxiety and depres-
sion). All subjects underwent two consecutive nights of
polysomnography in a research setting. Three of these
patients had a seizure during one of the two nights of base-
line recording, and were therefore excluded from analysis
of the FNE, given concerns about possible disruption
of sleep architecture and respiratory patterns after the
seizure. In these subjects with seizures (one had seizures
on both nights and two had seizures only on night one), it
was noted that the AHIs were above 5 on both nights.
Table 2 lists the means and standard deviations for sleep
and respiratory parameters assessed and compared over
the two nights. These include sleep latency, minutes and
percentages of stages 1 and 2 sleep, REM and SWS, arous-
als, AHI, and minimum oxygen saturation. Compared to
normative adult data, our epilepsy patients had more
stages 1 and 2 sleep on both nights, and less REM and
SWS on both nights than the usual control subjects
(Carskodon & Dement, 2000). Differences between the
first and the second night of PSG were seen in the average
REM sleep time in minutes, in the proportion of REM
sleep, and in the total minutes of SWS, all of which were
higher on the second night than the first. The total sleep
Table 2. Sleep architecture/AHI comparisons, first versus second night
Mean Standard Significance (2-tailed, Normative range
Variable Median value deviation Wilcoxon Signed-Rank test) (Carskodon, 2000)
Total sleep time (TST)
Night1 365.0 363.8 60.70 p¼ 0.05a
Night 2 376.7 386.3 68.06
Sleep efficiency (TST/record time)
Night1 81.8 79.9 10.87 p¼ 0.40
Night2 82.3 81.9 9.63
Sleep latency (minutes)
Night 1 12 21.5 24.65 p¼ 0.69
Night 2 12.8 21.4 27.40
Wake after sleep onset (minutes)
Night 1 64.7 73.1 47.7 p¼ 0.58
Night 2 58.7 69.3 48.4
Stage 1 (min)
Night 1 35.7 46.2 35.4 p¼ 0.92
Night 2 37.5 43.1 26.0
Stage 1%
Night 1 9.7 13.5 11.8 p¼ 0.78 2–5%
Night 2 10.8 12.6 9.9
Stage 2 (min)
Night 1 241.6 230.9 74.1 p¼ 0.76
Night 2 228.0 234.4 67.3
Stage 2%
Night 1 64.9 62.1 14.5 p¼ 0.18 44–55%
Night2 59.8 60.0 13.1
Stages 3–4 (SWS min)
Night 1 28.0 35.6 31.8 p¼ 0.01a
Night 2 42.8 46.4 37.9
Stages 3–4 (SWS)%
Night 1 8.8 11.7 10.2 p¼ 0.37 13–23%
Night 2 10.7 12.2 9.8
REM (min)
Night 1 39.5 48.7 27.3 p¼ 0.02a
Night 2 61 60.9 30.7
REM%
Night 1 10.3 12.3 5.9 p¼ 0.007a 20–25%
Night 2 16.1 15.5 6.2
AHI (apnea hypopnea index)
Night 1 11.6 13.5 10.3 p¼ 0.66
Night 2 10.6 13.1 10.2
Oxygen saturation (minimum)
Night 1 87.0 85.4 7.5 p¼ 0.18
Night 2 87.0 87.0 4.0
aSignificant differences at two-sided 0.05 significance level based Wilcoxon signed-rank test.
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time was at the limit of significance (p ¼ 0.05). The most
important change was an increase in the percentage of
REM sleep during the second night (16% vs. 12% on
night 1). Minutes spent in SWS also increased, although
the proportion of the night spent in SWS did not, as the
total sleep time increased overall.
The AHI did not show a significant difference between
the two nights of recording. The absolute AHI difference
ranged from 0 to 52, but the median difference was 3.25
(95% CI: 2.7–4) and the differences were primarily seen
in those with high AHI scores (Fig. 1). The overall per-
centage of agreement between the AHI on the two nights
was 90% (8 € 28), with a kappa score of 0.73 (95% CI:
0.50–0.98) indicating moderate agreement between the
two nights. AHIs on the two nights had correlation coeffi-
ents of rho (Spearman) ¼ 0.73 and p ¼ 0.55. There were
no significant differences in AHI during REM or NREM
sleep between the two nights.
The threshold for diagnosis of OSA in these patients
was an AHI of 5 or greater. Only one patient met criteria
for OSA on the basis of the second night alone (AHI 3 in
night one and 5.8 in night two). Three patients had AHI >5
on the first night's study, but not the second. A total of
29 patients had an AHI over 5 on both nights and seven
patients had an AHI below 5 both nights.
Discussion
In our cohort of refractory epilepsy patients undergoing
PSG within a multisite pilot clinical trial, the differences
in sleep architecture between first and second night PSG
studies were limited to a borderline increase in total sleep
time and an increase in REM sleep and SWS during the
second night. Our findings are comparable to our prior
work demonstrating a trend for higher total sleep time and
higher proportion of SWS on night 2. Previous studies of
FNEs in control groups have shown substantial sleep
latency changes (Tamaki et al., 2005) that were not appar-
ent in this epilepsy group. Our population showed sleep
architecture differences from control subjects similar to
those that have been described previously in epilepsy
(Sammaritano & Therrien, 2002). Specifically, our
patients had more light sleep, shorter sleep latency, and
less REM and SWS than normal control subjects. Sleep
latency in those with increased daytime somnolence may
be more rapid on the first laboratory night, and previous
Figure 1.
Bland–Altman agreement plot of night 1 and night 2 AHI. The differences of AHI from nights 1 and 2 are plotted
against the averages of the two measurements. Horizontal lines are drawn at the mean difference, and at the mean
difference plus and minus two times the standard deviation of the differences. The funnel pattern in the plot shows
larger AHI values tended to be more variable between the nights. (However, this should not affect results of nights 1
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experience with EEG testing might make the setting less
challenging. Still, the amount of REM and SWS increased
significantly during the second night of recording in our
epilepsy patients. The differences we noted between the
first and second nights of recording may be relevant for
detailed subsequent studies in this population; studies of
sleep architecture may benefit from a two-night paradigm.
This is the first study to comprehensively analyze respi-
ratory parameters in this population; we found no signifi-
cant differences in AHI between the first and second night
of study despite increased REM sleep on night 2. One
might have anticipated that nights with increased REM
sleep would have shown a higher AHI, but this was not the
case. In the normal adult population, in children, and in
the elderly, deeper sleep and higher AHI has been reported
during the second night of study in some series (LeBon
et al., 2000; Li et al., 2004). In our patients with epilepsy,
neither total AHI, nor AHI in REM and NREM, nor mini-
mum oxygenation documented any significant differences
between the two nights. Although the Bland–Altman
analysis did show greater variability in those with higher
AHIs between the two nights, there was no substantial
FNE on the ability to diagnose sleep apnea in this popula-
tion of refractory epilepsy patients. Possible explanations
for the lack of significant difference in respiratory parame-
ters in this group may include the fact that sleep is dis-
rupted at baseline by epileptiform discharges or changes
in sleep maintenance. The effects of sleep disruption in a
laboratory on respiratory parameters may be significantly
less than the effects of altered cerebral electrophysiologic
function in this group of patients with epilepsy and
exposure to diverse medications with CNS effects.
Several other subgroups have been studied in whom the
FNE may not cause substantially lower recognition of
OSA after a single sleep study. In children, sleep architec-
ture was different, but OSA did not differ by night in one
series (Scholle et al., 2003) and another author proposed
that it was probably not necessary to study pediatric
patients for two nights (Li et al., 2005). Most recently, it
has been discovered that older children had much less
FNE for respiratory parameters than younger ones
(Verhulst et al., 2006). A study of psychiatry patients also
showed they have significantly less marked FNE than con-
trols (Toussaint et al., 1995).
Whatever the cause of the milder FNE on sleep
architecture and respiration in this epilepsy population,
we have documented that the second night of PSG
evaluation adds little to the overall detection of sleep-
disordered breathing in our sample of patients with
epilepsy. In our sample, 36 patients were ultimately
randomized to treatment for OSA; only one with very
mild apnea would have been excluded without a sec-
ond night of polysomnography, and overall the agree-
ment between the two nights for those with lower or
borderline AHIs was very good. In some unusual
clinical situations, a second night of polysomnography
may be useful. However, given the cost and burden of
an additional night of study to the research subject,
the second night may not be necessary for further
studies in this refractory epilepsy population.
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